Literature DB >> 17118853

Re-treatment with cetuximab in patients with severe hypersensitivity reactions to cetuximab. Two case reports.

Dorte L Nielsen, Per Pfeiffer, Benny Vittrup Jensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17118853     DOI： 10.1080/02841860600871764

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  4 in total

1.  Successful rechallenge of cetuximab following severe infusion-related reactions: a case report.

Authors:  Pei-Hung Chang; Jen-Seng Huang
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

2.  Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors:  M Fakih; M Vincent
Journal:  Curr Oncol       Date:  2010-07       Impact factor: 3.677

3.  Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.

Authors:  Per Pfeiffer; Camilla Qvortrup; Jon K Bjerregaard
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

Review 4.  Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer.

Authors:  Richard M Goldberg; Clara Montagut; Zev A Wainberg; Philippe Ronga; François Audhuy; Julien Taieb; Sebastian Stintzing; Salvatore Siena; Daniele Santini
Journal:  ESMO Open       Date:  2018-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.